Tamar
Tamar Admon, Tel Aviv IL
Patent application number | Description | Published |
---|---|---|
20110161959 | Batch Job Flow Management - Systems and methods for improved batch flow management are described. At least some embodiments include a computer system for managing a job flow including a memory storing a plurality of batch queue jobs grouped into Services each including a job and a predecessor job. A time difference is the difference between a scheduled job start time and an estimated predecessor job end time. Jobs with a preceding time gap include jobs immediately preceded only by non-zero time differences. The job start depends upon the predecessor job completion. The computer system further includes a processing unit that identifies jobs preceded by a time gap, selects one of the Services, and traverses in reverse chronological order a critical path of dependent jobs within the Service until a latest job with a preceding time gap is identified or at least those jobs along the critical path preceded by another job are traversed. | 06-30-2011 |
Tamar Ashlagi Amiri, Kibbutz Ma'Ayan Zvi IL
Patent application number | Description | Published |
---|---|---|
20120273414 | DIFFUSION AERATION FOR WATER AND WASTEWATER TREATMENT - A system for treating wastewater including at least one water-treatment pathway having at least one wastewater inlet, at least one oxygen-permeable, water-impermeable wall, separating an interior of the pathway from outside air, and at least one treated wastewater outlet and arranged for at least aerobic treatment of the wastewater as it flows from the at least one wastewater inlet to the at least one treated wastewater outlet, at least one wastewater supply conduit, supplying the wastewater to the at least one wastewater inlet of the water-treatment pathway and at least one treated wastewater conduit, supplying treated wastewater from the at least one treated wastewater outlet of the at least one water-treatment pathway. | 11-01-2012 |
20150108052 | DIFFUSION AERATION FOR WATER AND WASTEWATER TREATMENT - A system for treating wastewater including at least one water-treatment pathway having at least one wastewater inlet, at least one oxygen-permeable, water-impermeable wall, separating an interior of the pathway from outside air, and at least one treated wastewater outlet and arranged for at least aerobic treatment of the wastewater as it flows from the at least one wastewater inlet to the at least one treated wastewater outlet, at least one wastewater supply conduit, supplying the wastewater to the at least one wastewater inlet of the water-treatment pathway and at least one treated wastewater conduit, supplying treated wastewater from the at least one treated wastewater outlet of the at least one water-treatment pathway. | 04-23-2015 |
Tamar Auerbach-Nevo, Rehovot IL
Patent application number | Description | Published |
---|---|---|
20150238529 | PLASMA-SUPPLEMENTED FORMULATION - Provided herein is a plasma-supplemented fibrinogen and/or fibrin formulation, method for the preparation and use thereof. | 08-27-2015 |
Tamar Barzuza, Tel Aviv IL
Patent application number | Description | Published |
---|---|---|
20150213650 | PRESENTATION OF ENHANCED COMMUNICATION BETWEEN REMOTE PARTICIPANTS USING AUGMENTED AND VIRTUAL REALITY - Embodiments disclosed herein provide methods, systems, and computer readable storage media for presenting a meeting between remote participants. In a particular embodiment, a method provides, during a conference session, compiling view information used to determine a first view seen by the first participant. The method further provides receiving conference video comprising at least video captured of a second participant remote to the physical location of the first participant. Also, the method provides presenting the video captured of the second participant such that the second participant appears at a first position of a meeting location in the first view to the first participant. | 07-30-2015 |
20150215351 | CONTROL OF ENHANCED COMMUNICATION BETWEEN REMOTE PARTICIPANTS USING AUGMENTED AND VIRTUAL REALITY - Embodiments disclosed herein provide methods, systems, and computer readable storage media for facilitating controlling a meeting between remote Augmented Reality (AR) and Virtual Reality (VR) participants. In a particular embodiment, a method provides, during a conference session wherein a plurality of head mounted displays (HMDs) are each worn by one of a plurality of participants, compiling first orientation information and first view information from a first HMD of the plurality of HMDs. The orientation information describes current orientation of the first HMD. Based on the first orientation information and the first view information, the method provides determining a first change to how video is presented the first HMD. Also, the method provides directing the first HMD to implement the first change. | 07-30-2015 |
20150215581 | ENHANCED COMMUNICATION BETWEEN REMOTE PARTICIPANTS USING AUGMENTED AND VIRTUAL REALITY - Embodiments disclosed herein provide methods, systems, and computer readable storage media for facilitating enhanced visual communication between remote participants. In a particular embodiment, a method provides, during a conference session, receiving first video captured of a first participant remote to a physical meeting location. The method further provides determining a first position for the first participant in the physical meeting location and determining a view of an Augmented Reality (AR) head mounted display worn by a second participant at the physical meeting location. From the first video, the method provides generating AR video that makes the first participant appear to the second participant at the first position when viewed through the AR head mounted display. The method also includes transferring the AR video to the AR head mounted display for presentation to the second participant. | 07-30-2015 |
Tamar Ben-Mordechai, Rishon Lezion IL
Patent application number | Description | Published |
---|---|---|
20130129810 | IRON OXIDE NANOPARTICLES FOR USE IN TREATING NON-INFECTIOUS INFLAMMATORY DISORDERS - In accordance with the present disclosure there are provided iron oxide nanoparticles for use in the treatment of non-infectious inflammatory disorders. Also provided by the present disclosure is a method of treatment of non-infectious inflammatory disorders making use of such particles, pharmaceutical compositions and kits comprising such particles | 05-23-2013 |
Tamar Ben-Porath, Herzliya IL
Patent application number | Description | Published |
---|---|---|
20160049068 | MOBILE PERSONAL SECURITY SYSTEM - A mobile personal security device, system and method to accept an activation signal of the system on a mobile device. An input of a periodicity setting is also accepted to indicate one of a series of time periods during which the system expects a security code to be inputted into the device. If the code is inputted into the device during one or each interval, then the interval is reset to expect a further inputting of the code during a subsequent interval. If the code is not received, an alarm signal may be issued. | 02-18-2016 |
Tamar Ben-Porath, Herzeliya IL
Patent application number | Description | Published |
---|---|---|
20150281930 | MOBILE PERSONAL SECURITY SYSTEM - A mobile personal security device, system and method are disclosed. The personal security device and system may include a portable communication or computing device having a positioning device, and adapted to communicate with a server to provide location based information and alerts to an Emergency Call Center (ECC), operate an imaging system of the portable device to obtain images and send them to the server via a network, set an alarm and play a recorded notice when an indication of an emergency is received from a user. A method according to one embodiment comprises initiating a personal security application on the portable device, providing a fixed location of a user or locating a user and tracking the user's location via a positioning device, translating the received position or positions to an address or a route of the user, and upon indication of emergency, automatically call an ECC, initiate an alarm, play a recorded notice and/or obtain images, via a front and/or rear imagers of the portable computing or communication device and send the images to a remote server via a communication network. | 10-01-2015 |
Tamar Ben-Yedidia, Mazkeret Batya IL
Patent application number | Description | Published |
---|---|---|
20090304730 | INFLUENZA VACCINE - The present invention relates to influenza vaccines for human and veterinary use. In particular, the present invention provides a vaccine able to effect long term and cross-strain protection by including at least two influenza virus epitopes expressed as a chimeric polypeptide wherein at least one epitope is influenza A virus matrix protein epitope and the second epitope is a haemagglutinin peptide epitope. | 12-10-2009 |
20100021489 | Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection - Polynucleotides and polypeptides which participate in influenza virus infection of cells and nucleic acid molecules, which include a polynucleotide sequence capable of specifically binding the polypeptides of the present invention. Also provided are methods of using such nucleic acid molecules, polynucleotides and antibodies directed thereagainst for diagnosing, treating and preventing influenza virus infection. | 01-28-2010 |
20110182974 | MULTIMERIC MULTIEPITOPE INFLUENZA VACCINES - The present invention relates to multimeric multi-epitope peptide-based vaccines. In particular, the present invention relates to the use of multimeric multi-epitope peptide-based vaccines eliciting protective immunity to influenza. | 07-28-2011 |
20130079390 | NUCLEIC ACID MOLECULES, POLYPEPTIDES, ANTIBODIES AND COMPOSITIONS FOR TREATING AND DETECTING INFLUENZA VIRUS INFECTION - Polynucleotides and polypeptides which participate in influenza virus infection of cells and nucleic acid molecules, which include a polynucleotide sequence capable of specifically binding the polypeptides of the present invention. Also provided are methods of using such nucleic acid molecules, polynucleotides and antibodies directed thereagainst for diagnosing, treating and preventing influenza virus infection. | 03-28-2013 |
20140286982 | MULTIMERIC MULTIEPITOPE INFLUENZA VACCINES - An isolated polynucleotide encoding an influenza multi-epitope polypeptide, wherein the multi-epitope polypeptide comprises multiple copies of a plurality of influenza virus peptide epitopes wherein the polypeptide is B(X | 09-25-2014 |
Tamar Clarke, Ascot GB
Patent application number | Description | Published |
---|---|---|
20150075933 | LUGGAGE APPARATUS - A luggage apparatus is described. The luggage apparatus comprises an apparatus body having a moveable portion and a fixed portion, the moveable portion being movable with respect to the fixed portion between a deployed position and a stowed position. In the deployed position, a moveable portion surface and a fixed portion surface are arranged to define a seat for a child and in the stowed position, the moveable and fixed portion surfaces are substantially contained within the luggage apparatus body | 03-19-2015 |
Tamar Cohen, Oakland, CA US
Patent application number | Description | Published |
---|---|---|
20090241041 | POSITION CODE BASED CONTENT DEVELOPMENT METHOD AND TOOL - Computerized content development methods and tools are disclosed. In one embodiment, a method includes generating a title by assigning one or more functions to respective portions of one or more position-coded pages through a graphical user interface which does not require a code level programming, and automatically converting the title to a format operable by computing device which interacts with a printed medium of the position-coded pages to perform the functions. | 09-24-2009 |
Tamar Ekstein, New York, NY US
Patent application number | Description | Published |
---|---|---|
20120282317 | Medicated popsicle system - A system for providing medication in an edible frozen form consists of a popsicle mold, a popsicle holder with a core stick, handle and drip guard, and a liquid mixture containing sweeteners, edible colorants, and flavorings which is individually mixed with medication for each popsicle in order to add a custom flavoring to mask the taste of the medicine and encourage consumption by children. The system also includes a mixing implement and storage for the mixing implement incorporated into the popsicle mold, writable and erasable areas on the mold where information particularly relevant to the medicine type, dosage and administration schedule can be written and then changed as needed, an erasable writing implement, and storage for the writing implement incorporated into the popsicle mold. | 11-08-2012 |
Tamar Ellam, New York City, NY US
Patent application number | Description | Published |
---|---|---|
20090094576 | Pattern-Based Development of Computer System Solutions - The problems that normally attend the development and deployment of a computer system solution are reduced by employing patterns and virtual images in the development and deployment process. When information had been acquired about a data processing need to be met, pattern representing a generalized solution to that need is selected. A set of previously-developed virtual images supporting the selected pattern is chosen. Once information representing the specific need is received, the selected pattern is modified to represent a specific solution. Parameters are obtained for the specific solution and a set of scripts integrating the parameters is generated. The scripts are used to reconfigure the virtual images. The reconfigured virtual images are combined into a computer system solution that can be loaded and run with little or no further configuration. | 04-09-2009 |
Tamar Garmizo, Tel Aviv IL
Patent application number | Description | Published |
---|---|---|
20090242732 | Apparatus for making ice glasses, bowls and candleholders - A one-piece apparatus for making ice glasses using a regular glass. The apparatus is shaped like a cylindrical nipple with a dome-shaped head that gradually widens until it turns into a round base with a protruding rim around its circumference. The apparatus is used with a regular glass with a uniform rim, and the freezing action takes place with the regular glass upside down. Use of the apparatus is simple and efficient. First, a regular glass is filled with water. Then the apparatus is inserted into the regular glass so that the nipple is facing the bottom of the glass. Next, the regular glass is turned upside down, with the apparatus in it, and placed in the freezer. After the water has frozen, the apparatus and the regular glass are separated and an ice glass is obtained. | 10-01-2009 |
Tamar Gelles, Haifa IL
Patent application number | Description | Published |
---|---|---|
20110066609 | Crawling Browser-Accessible Applications - Crawling a browser-accessible application by causing a target application and a bridge application to run concurrently in a browser-controllable player, and iteratively receiving from the bridge application current state information of the target application, storing the state information on a data storage device if the state information is not found on the data storage device, where the state information is stored as a descendant state of an initial state of the target application, and interacting with the target application in accordance with a predefined simulation algorithm, thereby effecting a new state of the target application, until a predefined termination condition is reached. | 03-17-2011 |
20120253778 | Crawling Browser-Accessible Applications - Crawling a browser-accessible application by causing a target application and a bridge application to run concurrently in a browser-controllable player, and iteratively receiving from the bridge application current state information of the target application, storing the state information on a data storage device if the state information is not found on the data storage device, where the state information is stored as a descendant state of an initial state of the target application, and interacting with the target application in accordance with a predefined simulation algorithm, thereby effecting a new state of the target application, until a predefined termination condition is reached. | 10-04-2012 |
Tamar Ginsburg-Shmuel, Ra'Anana IL
Patent application number | Description | Published |
---|---|---|
20130324495 | URIDINE DI- OR TRI-PHOSPHATE DERIVATIVES AND USES THEREOF - The invention provides particular uridine di- and tri-phosphate derivatives, and pharmaceutical compositions thereof. These compounds are useful for treatment of diseases, disorders and conditions modulated by P2Y6 receptors, and particularly for lowering intraocular pressure and thereby treating ocular hypertension and/or glaucoma. | 12-05-2013 |
Tamar Jehuda-Cohen, Moshav Gimzo IL
Patent application number | Description | Published |
---|---|---|
20130216999 | METHODS AND KITS FOR THE DETECTION OF AN INFECTION IN SUBJECTS WITH LOW SPECIFIC ANTIBODY LEVELS - This invention relates to methods that enable the detection of antibodies against a latent infection, a chronic infection, a re-infection, and/or a breakthrough infection; enable the diagnosis of a latent infection, a chronic infection, a re-infection, and/or a breakthrough infection; and increase low anti-viral antibody levels, and a kit for the detection of virus-specific antibodies expressed at low levels. | 08-22-2013 |
20140065601 | METHOD AND KIT FOR ESTIMATING HUMAN IMMUNODEFICIENCY VIRUS (HIV) INCIDENCE - The present invention provides a method for determining the incidence of human immunodeficiency virus (HIV) infections in a population comprising comparing the anti-HIV antibody levels of in vitro stimulated tissue samples to those of un-stimulated tissue samples from individual members of said population and related kits. The present invention also provides a method of determining the distribution of recent, non-recent, and late stage human immunodeficiency virus (HIV) infections in a population comprising comparing the in vitro stimulated anti-HIV immunoreactivity and un-stimulated anti-HIV immunoreactivity in tissue samples from individual members of said population and related kits. | 03-06-2014 |
20140087364 | METHOD AND KIT FOR DETERMINING THE TIME OF SEROCONVERSION OF A PATIENT INFECTED WITH A VIRUS - The present invention provides a method for determining the time of infection, and a method for determining if a microbial infection is in the early stages comprising the step of determining the ratio of in vitro stimulated anti-microbial immunoreactivity and un-stimulated anti-microbial immunoreactivity in blood samples from said subject and related kits. | 03-27-2014 |
20150111767 | METHOD AND KIT FOR THE DETECTION OF HEPATITIS-SPECIFIC ANTIBODIES - The present invention relates to an improved method for detecting antibodies to a hepatitis virus in a tissue sample from individuals, which can reliably detect antibodies in recently infected individuals and which provides much lower false positive results in individuals that have cleared their hepatitis infections. More particularly, the present invention relates to an improved method and kit which utilizes an activator of (i) hepatitis virus-primed lymphocytes, (ii) memory cells specific for said hepatitis virus, (iii) hepatitis virus-specific antibody production, or (iv) a combination thereof in a tissue sample to stimulate the production of antibodies from newly primed B cells, if present. | 04-23-2015 |
20150330980 | METHODS AND KITS FOR THE DETECTION OF VIRAL INFECTIONS - The invention relates to an improved assay for detecting antibodies in a tissue sample from individuals who test seronegative by conventional assay techniques, thus aiding in the diagnosis of possible pathogenic infections. Specifically, the invention relates to improved assay methods and kits that enable efficient detection of antibodies against a viral infection. | 11-19-2015 |
Tamar Kalcar, Klachim IL
Patent application number | Description | Published |
---|---|---|
20090125435 | Trading Plaftorm System and Method for Diamond and Precious Stone Transactions - The transaction method and system facilitates sales of diamonds or stones. A searchable database of stones includes, for each stone, an offer to sell, a weight-carat, other stone characteristics and an electronic copy of a grading lab certificate which uniquely identifies each stone from all other stones in the database. A search displays, for each stone, the offer and stone weight, stone characteristics and electronic access to the stone's certificate. The system permits a prospective buyer to “buy now,” which closes the transaction at the posted offer, or “bid now” wherein the system logs a bid value and an expiry time. Other bids are posted and displayed, in a primacy order until (a) the seller “buy now at the bid” or (b) withdraws the offer or (c) replaces the offer with a subsequent offer. Preferably, offers: displayed in time sequence and bids: displayed by primacy of price and expiry. | 05-14-2009 |
Tamar Kashti, Rehovot IL
Patent application number | Description | Published |
---|---|---|
20110279831 | REDUCING THE VISIBILITY OF COLOR CHANGES CAUSED BY COLOR PLANE REGISTRATION VARIATIONS IN HALFTONE COLOR PRINTING - A set of screens is provided for use in printing respective color separations in a halftone color printing process. This set of screens comprises at least two clustered-dot screens and the frequency and angle parameter values of the screens is such that the lowest frequency moiré produced by any combination of at least two frequency components, taken from the group comprising the first and second screen harmonics, for which the sum of the harmonic orders of the frequency components in the combination is less than a predetermined value, is of a sufficiently high frequency as to be substantially unperceivable to the human visual system; other moirés are also substantially unperceivable to the human visual system. The lowest frequency moiré serves to reduce the visibility of color changes caused by color plane registration variations. A printing system and method employing the screen set are also provided. | 11-17-2011 |
20140320928 | HALFTONE SCREEN - A halftone screen may be used to transform a continuous tone image into a halftone image. Determining the halftone screen may include determining a first halftone tile for a first gray level, selecting pixel locations and increasing the intensity of pixels at the locations to activate the pixels to form a second halftone tile for a subsequent gray level. A filtered image may be generated from the second halftone tile, and pixels from the filtered image may be used to generate the halftone screen. | 10-30-2014 |
Tamar Katzav, Klachim IL
Patent application number | Description | Published |
---|---|---|
20090070236 | Diamond and Precious Stone Trading Platform with Funding and Delivery Transparency - The transparent diamond and precious stone trading platform and method has funding and delivery transparency during the buy-order, funding, and tracking pickup, independent comparative inspection, and final delivery of each stone. The database of stones includes, for each stone, stone-weight, stone characteristics, price, and a grading lab certificate. The certificate uniquely identifies each stone and is electronically accessible by sellers, buyers, couriers, and authentication services. A buy command is communicated to seller and buyer. The transfer funds is electronically noted and communicated. The pickup by courier, interim delivery, inspection comparing the stone to the certificate, and subsequent delivery to buyer and release of funds is communicated to traders by emails, text messages, automated voice messages or IVR. Buyer and seller profiles establish communications channels and organizational managers are also permitted access and given communications. If time or place parameters are exceeded, increasing levels of alarm electronic communications are implemented. | 03-12-2009 |
Tamar Kaully, Adi IL
Patent application number | Description | Published |
---|---|---|
20090162447 | Spherically Shaped Substances - A particle having a rounded shape and characterized by a substantially smooth surface is disclosed. The particle can be made of a food substance (e.g., nutritional substance or nutraceutical substance), a pharmaceutical (pharmaceutically active ingredient or pharmaceutically acceptable carrier) or a cosmetic substance. | 06-25-2009 |
20100288404 | Highly-Filled, High-Viscosity Paste Charge, And Method And Device For Production Thereof - A highly-filled paste, and a method and device of de-aerating and injecting the paste, the paste including: (a) a solid filler; (b) an organic binder, and (c) a residual gas, wherein the paste contains at least 80 volume-% of the solid filler and has a viscosity exceeding 100 kilopascal·seconds, wherein the filler, binder, and residual gas are intimately mixed so as to form a substantially homogeneous paste, and wherein a composition of the solid filler, binder, and residual gas is selected such that the homogeneous paste has: an average density greater than 98.5% of a Theoretical Maximum Density (TMD). | 11-18-2010 |
20110168950 | SIMULANT MATERIAL AND METHOD FOR MANUFACTURE THEREOF - Provided is a simulant material for simulating hazardous materials, including a quantity of at least one explosive material and at least one inert material. The simulant material is a non-explosive material and is in the form of a homogenous, flexible and non-particulated material. Also provided is a method for manufacturing such a simulant material. | 07-14-2011 |
20110209600 | Highly-Filled, High-Viscosity Paste Charge, And Method And Device For Production Thereof - A highly-filled paste, and a method and device of de-aerating and injecting the paste, the paste including: (a) a solid filler; (b) an organic binder, and (c) a residual gas, wherein the paste contains at least 80 volume-% of the solid filler and has a viscosity exceeding 100 kilopascal·seconds, wherein the filler, binder, and residual gas are intimately mixed so as to form a substantially homogeneous paste, and wherein a composition of the solid filler, binder, and residual gas is selected such that the homogeneous paste has: an average density greater than 98.5% of a Theoretical Maximum Density (TMD). | 09-01-2011 |
20110209805 | Highly-Filled, High-Viscosity Paste Charge, And Method And Device For Production Thereof - A highly-filled paste, and a method and device of de-aerating and injecting the paste, the paste including: (a) a solid filler; (b) an organic binder, and (c) a residual gas, wherein the paste contains at least 80 volume-% of the solid filler and has a viscosity exceeding 100 kilopascal·seconds, wherein the filler, binder, and residual gas are intimately mixed so as to form a substantially homogeneous paste, and wherein a composition of the solid filler, binder, and residual gas is selected such that the homogeneous paste has: an average density greater than 98.5% of a Theoretical Maximum Density (TMD). | 09-01-2011 |
20110293722 | HYDROGEL SPONGES, METHODS OF PRODUCING THEM AND USES THEREOF - A macroporous hydrogel sponge is provided selected from: (i) a synthetic polymer hydrogel sponge, and (ii) a synthetic polymer-polypeptide conjugate hydrogel sponge, the macroporous hydrogel sponge being at least 20% porous and having a pore diameter of 50-1000 μm, wherein said synthetic polymer is crosslinked to an extent determined by effecting the crosslinkig of the synthetic polymer or synthetic polymer-polypeptide conjugate in the presence of at least about 30% by weight crosslinking agent. | 12-01-2011 |
Tamar Paz-Elizur, Rehovot IL
Patent application number | Description | Published |
---|---|---|
20110294134 | METHODS AND KITS FOR DETERMINING A RISK TO DEVELOP CANCER, FOR EVALUATING AN EFFECTIVENESS AND DOSAGE OF CANCER THERAPY AND FOR CORRELATING BETWEEN AN ACTIVITY OF A DNA REPAIR ENZYME AND A CANCER - Methods and kits for (i) determining a risk of a subject to develop cancer; (ii) evaluating an effectiveness and dosage of cancer therapy administered to a cancer patient; and (iii) determining a presence of correlation or non-correlation between an activity of at least one DNA repair enzyme and at least one cancer, are disclosed. | 12-01-2011 |
20140248293 | NOVEL RISK BIOMARKERS FOR LUNG CANCER - Methods and kits for determining a risk of a subject, or subjects for developing lung cancer is disclosed. The method comprises determining a level of catalytic activity of N-methylpurine DNA glycosylase (MPG), or apurinic/apyrimidinic endonuclease 1 (APE1), or both, or MPG and 8-oxoguanine DNA glycosylase (OGG1), or MPG and APE1 and OGG1 in peripheral blood cells of a subject, wherein levels of MPG above a predetermined reference value, or APE1 or OGG1, or a integrated DNA repair score below a predetermined reference value is indicative of an increased risk of developing lung cancer. | 09-04-2014 |
Tamar Peretz-Yablonsky, Jerusalem IL
Patent application number | Description | Published |
---|---|---|
20110097271 | Colon Cancer Associated Transcript 1 (CCAT1) As A Cancer Marker - The present invention relates to the identification, isolation, and sequencing of a unique nucleic acid transcript termed Colon Cancer Associated Transcript 1 (CCAT-1) that is specifically expressed in cancer cells, in particular in colon, rectal, and lung cancer, as well as in precancerous lesions. The present invention thus provides methods for diagnosing cancer by detecting the expression of CCAT-1 as well as isolated polynucleotides, compositions and kits for use in the detection methods of the invention. | 04-28-2011 |
Tamar Prez-Menahemov, Jerusalem IL
Patent application number | Description | Published |
---|---|---|
20110086813 | COMPOUNDS FOR TREATING BACTERIAL INFECTIONS - The present invention relates to a novel class of guanine nucleotide analogs which inhibit RelA and Relseq synthetic activity and which possess anti-bacterial activity. The present invention also relates to pharmaceutical compositions that include such compounds, and to methods of use of such compounds or compositions for combating bacteria and treating bacterial infections. | 04-14-2011 |
Tamar Ravon, Ramat Aviv IL
Patent application number | Description | Published |
---|---|---|
20090322378 | Electrical Device For Performing Logic Functions - An electronic device is presented for performing at least one logic function. The device comprises an electron emission based electrode arrangement associated with an electron extractor. The electrode arrangement comprises at least one basic unit including a photocathode, an anode, and one or more gates arranged aside a cavity defined between the photocathode and the anode. Said one or more gates are connectable to a voltage supply unit to be operated by one or more input voltages signals corresponding to one or more logical values, respectively. Said anode is operable as a floating electrode from which an electrical output of the device indicative of a resulted logic function is read. The anode is electrically connected to a photocathode of another cathode-anode unit of the same device, or is connected to an electrode of another electronic device. | 12-31-2009 |
20110042550 | Image Sensor Cell for Night Vision - An image sensor cell ( | 02-24-2011 |
20110128784 | NON-VOLATILE MEMORY DEVICE - An electronic memory device is presented. The device comprises at least one basic unit (FIG. | 06-02-2011 |
Tamar Rubinek, Or Yehuda IL
Patent application number | Description | Published |
---|---|---|
20100330062 | KLOTHO PROTEIN AND RELATED COMPOUNDS FOR THE TREATMENT AND DIAGNOSIS OF CANCER - Disclosed is the use of a klotho protein or related compounds for the diagnosis and treatment of cancer, alone or together with other active pharmaceutical ingredients such as chemotherapeutic agents or hormone-regulating agents. | 12-30-2010 |
20110046071 | GLP-1 Receptor Agonists And Related Active Pharmaceutical Ingredients For Treatment Of Cancer - Disclosed are methods and compositions for increasing concentrations of GLP-1 receptor agonists in the body for the treatment of cancer, alone or together with other active pharmaceutical ingredients such as chemotherapeutic agents or hormone-regulating agents. | 02-24-2011 |
20120014927 | METHODS AND KITS FOR DETERMINING PREDISPOSITION TO CANCER - Provided are methods and kits for determining predisposition to cancer by determining the presence or absence in a heterozygote form of the KLOTHO functional variant. Also provided are methods of designing treatment and treating cancer based on the increased predisposition to the cancer, and to determine the prognosis of a subject diagnosed with cancer. | 01-19-2012 |
20120172314 | Klotho Protein and Related Compounds for the Treatment and Diagnosis of Cancer - Disclosed is the use of a klotho protein or related compounds for the diagnosis and treatment of cancer, alone or together with other active pharmaceutical ingredients such as chemotherapeutic agents or hormone-regulating agents. | 07-05-2012 |
20120178699 | KLOTHO PROTEIN AND RELATED COMPOUNDS FOR THE TREATMENT AND DIAGNOSIS OF CANCER - Disclosed is the use of a klotho protein or related compounds (especially KL1 or KL1 analogue) for treatment, and especially treatment of cancer, alone or together with other active pharmaceutical ingredients such as chemotherapeutic agents. | 07-12-2012 |
20150079065 | KLOTHO VARIANT POLYPEPTIDES AND USES THEREOF IN THERAPY - Disclosed are Klotho variant proteins in which residue Glu414 and/or residue Asp238 is substituted with an amino acid different than L-Glu or L-Asp, respectively, as well as polynucleotides encoding the variant proteins, and the use thereof in therapy, especially for the treatment of cancers, especially breast cancer and pancreatic cancer. | 03-19-2015 |
Tamar Saison, Paris FR
Patent application number | Description | Published |
---|---|---|
20120141795 | BISMUTH VANADATE PARTICLES AND THE METHOD FOR PRODUCING SAME - The subject of the invention is a method for obtaining particles of chemical formula BiVO | 06-07-2012 |
20150159365 | HIGH PERFORMANCE THERMAL INSULATION PRODUCTS - The manufacture of a thermal insulating product whereby a foam is produced from a mixture of mineral particles, the product is shaped, and the foam is dried. Specifically, the foam is produced from a crystallized calcic part and a crystallized magnesian part, and a composite aggregate of the crystals of the calcic and magnesian part is formed. The calcic part is chosen from calcite and/or aragonite, and the magnesian part is made of hydromagnesite. | 06-11-2015 |
Tamar Smith-Norowitz, Brooklyn, NY US
Patent application number | Description | Published |
---|---|---|
20090041781 | METHODS FOR DETECTING PARVOVIRUS INFECTIONS - The present invention provides a method for diagnosing a subject suffering a pathological condition characterized by parvovirus infection by detecting the presence of IgE anti-Parvovirus B 19 antibodies. | 02-12-2009 |
Tamar Tchkonia, Rochester, MN US
Patent application number | Description | Published |
---|---|---|
20140189897 | TRANSGENIC ANIMALS CAPABLE OF BEING INDUCED TO DELETE SENESCENT CELLS - This document relates to methods and materials involved in the removal of senescent cells within a mammal. For example, transgenic non-human animals that can be induced to delete senescent cells are provided. | 07-03-2014 |
20150296755 | TRANSGENIC ANIMALS CAPABLE OF BEING INDUCED TO DELETE SENESCENT CELLS - This document relates to methods and materials involved in the removal of senescent cells within a mammal. For example, transgenic non-human animals that can be induced to delete senescent cells are provided. | 10-22-2015 |
Tamar Traitel, Beer Sheva IL
Patent application number | Description | Published |
---|---|---|
20150366979 | POSITIVELY CHARGED POLYSACCHARIDES FOR RNA TRANSFECTION - A complex includes RNA and a positively charged modified polysaccharide selected from starch, amylose, amylopectin, galactan, chitosan, or dextrin. The complex can be formed into a pharmaceutical composition. The complex can be used in methods for RNA transfection, gene therapy and treatment of a disease, disorder or condition. The positively charged modified polysaccharide can be used in connection with RNA transfection into cells. | 12-24-2015 |
Tamar Triatel, Beer-Sheva IL
Patent application number | Description | Published |
---|---|---|
20110319790 | PHARMACEUTICAL COMPOSITION AND SYSTEM FOR PERMEABILIZING FETAL MEMBRANES - Provided is a pharmaceutical composition for permeabilizing fetal membranes including an active ingredient having a log K in the range of 2 to 4, where K is the octanol/water partition coefficient. The active ingredient may be, for example, bupivacaine, sodium lauryl sulfate or oleic acid. Further provided is a system for transfetal membrane transport. The system includes a probe unit adapted for insertion into a female reproductive tract and releasing a substance onto fetal membranes that permeabilizes the membranes. The system is also configured to apply ultrasound radiation to the fetal membranes to further increase the membrane permeability. | 12-29-2011 |
Tamar Tzioni, Jerusalem IL
Patent application number | Description | Published |
---|---|---|
20090017129 | Dead Sea minerals enriched anti-inflammatory pharmaceutical composition for treatment of cutaneous dryness, itching, peeling and tightness, especially in hemodialysis patients and preparation and treatment methods thereof - This invention relates to Dead Sea anti-inflammatory medicaments or cosmetics for treatment of anti-inflammatory conditions; for example, cutaneous dryness, itching, peeling, and tightness, especially in hemodialysis patients. Methods for the preparation of and methods of treatment using these medicaments or cosmetics are also provided. | 01-15-2009 |
Tamar Yechezkel, Ramat-Gan IL
Patent application number | Description | Published |
---|---|---|
20090156507 | Cell permeable conjugates of peptides for inhibition of protein kinases - The present invention provides inhibitors of protein kinases comprising a molecule having at least a first moiety competent for penetration of the molecule into cells, and a second moiety for having a protein kinase inhibiting effect within the cells. The first moiety is joined to the second moiety through a linker or a spacer. The complex molecules are preferably peptide conjugates having improved cell-permeability, serum stability and kinase selectivity compared to known protein kinase inhibitors. Pharmaceutical compositions that include these protein kinase inhibitors, and methods of using such compositions for treatment of cancers and other diseases associated with protein kinase activity are also disclosed. | 06-18-2009 |
Tamar Yechezkel, Shoham IL
Patent application number | Description | Published |
---|---|---|
20110250144 | RGD-CONTAINING PEPTIDOMIMETICS AND USES THEREOF - The invention provides RGD-containing cyclic peptidomimetics; conjugates of said peptidomimetics and a moiety of a payload selected from fluorescent probes, photosensitizers, chelating agents, or cytotoxic agents; and pharmaceutical compositions comprising these conjugates. The conjugates of the invention are useful both for diagnostic purposes and treatment of various diseases, disorders and conditions. More specifically, conjugates comprising fluorescent probes can be used for diagnostic purposes, e.g., visualization of organs and tissues, and diagnosis of tumors; conjugates comprising photosensitizers can be used for photodynamic therapy of both tumors and nonneoplastic tissues; conjugates comprising chelating agents can be used in radio imaging or radiotherapy; and conjugates comprising cytotoxic agents can be used for in targeted chemotherapy. | 10-13-2011 |
20140154181 | RGD-CONTAINING PEPTIDOMIMETICS AND USES THEREOF - The invention provides RGD-containing cyclic peptidomimetics; conjugates of said peptidomimetics and a moiety of a payload selected from fluorescent probes, photosensitizers, chelating agents, or cytotoxic agents; and pharmaceutical compositions comprising these conjugates. The conjugates of the invention are useful both for diagnostic purposes and treatment of various diseases, disorders and conditions. More specifically, conjugates comprising fluorescent probes can be used for diagnostic purposes, e.g., visualization of organs and tissues, and diagnosis of tumors; conjugates comprising photosensitizers can be used for photodynamic therapy of both tumors and nonneoplastic tissues; conjugates comprising chelating agents can be used in radioimaging or radiotherapy; and conjugates comprising cytotoxic agents can be used for targeted chemotherapy. | 06-05-2014 |
Tamar Yehoshua, Sunnyvale, CA US
Patent application number | Description | Published |
---|---|---|
20100205059 | AD SERVER SYSTEM WITH CLICK FRAUD PROTECTION - An ad server system takes into consideration information about a user who clicks on an ad in determining whether to charge the advertiser for the click event, and/or in determining an amount to charge the advertiser. In one embodiment, unless the user is recognized, the advertiser is not charged for the ad selection event. Thus, advertisers do not have to pay the ad placement provider when the users who click on their ads are not recognized. If the user is recognized, the ad server system may determine whether and/or how much to charge the advertiser based on information about the recognized user. This information may include, for example, whether the user has set up an account, whether a valid credit card is on file for the user, and/or other types of user information that can be used to hold fraudulent users accountable for their actions. | 08-12-2010 |
20150302461 | SYSTEM AND METHOD FOR MULTIPLE USER ADVERTISEMENT ACCOUNTS - A multiple user advertisement account system includes an advertisement account database for storing information related to the account. The system is configured to grant multiple users access to the account and allow the users to view or update the information stored in the account database. The system tracks the updates to the information and generates a display of an activity log that contains entries related to the updates received. | 10-22-2015 |
Tamar Zioni, Motza Ilit IL
Patent application number | Description | Published |
---|---|---|
20100111878 | SKIN-CARE COMPOSITIONS AND USES THEREOF - Composition of a Dead Sea extract and at least one plant extract of a Himalayan origin are provided for topical applications. | 05-06-2010 |